Main page Statistics Risk factors Genetics Diagnosis
Blog Board News Directory Others


CADstream May Improve Diagnostic Accuracy in breast cancer

 Return to main news page

Breast cancer news 3/7/2005

    KIRKLAND, Wash.--(BUSINESS WIRE)--March 4, 2005-- Confirma today announced that an abstract being presented at the 2005 European Congress of Radiology (ECR), currently underway in Vienna, Austria, demonstrates that CADstream, computer-aided-detection (CAD) for breast MRI, may improve diagnostic accuracy and increase efficiency of breast MRI analysis. Over 9,000 radiology professionals are expected to attend this year's European Congress of Radiology, which is being held March 4 through 7.
    This abstract is entitled: "An Advanced Method of Computer-Aided-Evaluation Applied to Breast MRI: A Useful Tool Both for the Radiologist Analysis and for Diagnostic Accuracy," In this study Drs. J.C. Vilanova and J. Barcelo of Clinica Girona in Girona, Spain, compared CADstream to standard software used for MRI analysis, focusing on diagnostic accuracy and efficiency. The study concluded that CADstream may improve diagnostic accuracy and increased efficiency for breast cancer evaluation. The CAD system showed a significant reduction in image artifact, helping the radiologist with more accurate analysis and saving a substantial amount of time during analysis of breast MRI studies.
    The authors claim that the study shows that CADstream significantly reduces patient movement-related artifact and analysis time, assisting radiologists in more accurately and efficiently interpreting studies.
    About CADstream
    CADstream enhances the efficiency and workflow of breast MRI studies by automating data analysis, improving image management and correcting for patient movement, which assists radiologists in the interpretation, standardization and reporting of these data-intensive studies. CADstream's core automated features include adaptive image registration (2D/3D), multiplanar reformatting, subtractions, angiogenesis maps, interactive real-time contrast curves, maximum intensity projections (MIPs) and volume summaries. CADstream's advanced features include a streamlined portfolio for treatment planning (automatically provides summaries with size, classification and location for tumor volume of interest and incorporates ACR BI-RADS® Atlas for lesion classification), multimodality ready (ability to access and view patients' mammography and ultrasound studies while interpreting breast MRI studies) and SureLoc(TM) for interventional planning. Confirma will be showcasing CADstream at ECR in Hall A, Booth 134.